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Abstract
Background: Persistent dyspnea is a common finding in the cystic fibrosis patient that typically
leads to further work up of an alternative pulmonary etiology. Adult cystic fibrosis patients;
however, are growing in numbers and they are living into the ages in which coronary artery disease
becomes prevalent. Coronary disease should be included in the consideration of diagnostic
possibilities.
Case presentation: A 52-year-old white male with cystic fibrosis was evaluated for exertional
dyspnea associated with vague chest discomfort. Diagnostic testing revealed normal white blood
cell, hemoglobin and platelet count, basic metabolic panel, fasting lipid profile, HbA1c, with chest
radiograph confirming chronic cystic findings unchanged from prior radiographs and an
electrocardiogram that revealed sinus rhythm with left anterior fascicular block. Stress thallium
testing demonstrated a reversible anteroseptal perfusion defect with a 55% left ventricular ejection
fraction. Heart catheterization found a 99% occlusion of the left anterior descending artery
extending into the two diagonal branches, with 100% obstruction of the left anterior descending
artery at the trifurcation and 70% lesion affecting the first posterior lateral branch of the circumflex
artery.
Conclusion: This case report represents the first description in the medical literature of a cystic
fibrosis patient diagnosed with symptomatic coronary artery disease. Applying a standard clinical
practice guide proved useful toward evaluating a differential diagnosis for a cystic fibrosis patient
presenting with dyspnea and chest discomfort.
Background
Cystic Fibrosis (CF) is the most common lethal inherited
disease in the Caucasian population. It was once consid-
ered a childhood disease; however, with advances in
health care there is a growing population of adults with
CF [1]. A life expectancy that was only 8 years of age in
1974 had advanced to the age of 21 years in 1994, and
today is estimated as high as 40 years of age [2]. There are
patients on the Cystic Fibrosis Foundation Patient Regis-
try in 2003 that are in their eighth decade of life [1].
With new found longevity comes a new spectrum of dis-
ease prevalence associated with aging. Cystic Fibrosis
Related Diabetes (43% prevalence) is now the number
two chronic illness in the adult CF patient following
chronic lung disease and surpassing liver disease (24%
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prevalence) in patients greater than 30 years of age [3].
Cardiovascular disease has been essentially isolated to cor
pulmonale as a consequence of end stage obstructive pul-
monary disease. Hypertension has not been considered a
serious problem in this patient population [4]; however,
a 20% prevalence has been observed at our CF adult
center. Symptomatic coronary artery disease, one of the
most prevalent of diseases in the adult patient population,
has never been reported in the CF population from a
PubMed literature search to date. Guides for care of health
concerns in adult patients with CF were published in a
January 2004 Consensus Report to help transition CF
health care from pediatrician to internists or other adult
care providers [3]. Many aspects of cardiovascular discus-
sions such as hypertension and forms of heart disease sep-
arate from cor pulmonale are missing from this consensus
report. The following discussion illustrates the need to
continually update and add new information that will
lead to optimizing the care of adult CF patients.
Case presentation
A 52-year-old white male with CF presented with persist-
ent exertional dyspnea and cough with scant sputum pro-
duction. Physical examination demonstrated oxygen
saturation of 91%, with normal temperature and vital
signs. His weight had fallen from 79.2 to 77.1 kg over 3
months. Cardiovascular exam was entirely normal. Lungs
demonstrated coarse breath sounds bilaterally with scat-
tered rales throughout the lung fields. The abdomen was
normal, extremities demonstrated significant clubbing
and there was no peripheral edema. Forced expiratory vol-
ume at 1 second (FEV1) had decreased from 50% to 36%.
The chest radiograph resembled baseline findings with no
obvious infiltrate or pneumothroax. He received a month-
long course of azithromycin, aztreonam and inhaled
tobramycin for suspected pulmonary exacerbation of
acute super-infection in the setting of underlying chronic
CF lung disease.
One month later, follow-up revealed no improvement in
dyspnea and no change in the scant sputum production,
despite full adherence to the antibiotic regimen and air-
way clearance techniques. Exertional discomfort located
along the sternum and left anterior chest associated with
dyspnea without radiation or pressure sensation was fur-
ther described but was not associated with palpitations,
diaphoresis or nausea. This discomfort improved with rest
and was not associated with meals. He did report the need
to sleep upright in a recliner, but denied paroxysmal noc-
turnal dyspnea.
CF was diagnosed in this patient by sweat chloride at age
35 after an episode of hemoptysis, with subsequent
genetic analysis identifying a ∆F508, 2789+5G>A muta-
tion. He also has gastroesophageal reflux, Barrett's
esophagus, azoospermia, and pancreatic insufficiency. He
had sinus surgery at age 47. Medications include
albuterol, ipratropium, fluticasone, dornase alpha, salme-
terol, omeprazole, pancreatin and multivitamin. The
patient's father had a myocardial infarction at age 37, his
mother had coronary artery bypass surgery at 52 years of
age, and a brother underwent coronary bypass at age 61.
The patient has never smoked and alcohol intake was
minimal.
Diagnostic testing demonstrated normal white blood cell,
hemoglobin and platelet count. Electrolytes, albumin,
protein and glucose were normal with a 5.1% HbA1c.
Total cholesterol was 139 mg/dl, LDL 80 mg/dl, HDL 30
mg/dl and triglycerides at 76 mg/dl. Chronic findings
with cystic changes were evident on chest radiograph, but
with no obvious consolidation. Electrocardiogram
revealed sinus rhythm with a left anterior fascicular block
and normal ST findings.
Stress thallium testing was subsequently arranged within
a week of the follow up visit, with results positive for mod-
erate anteroseptal area of reversible perfusion with a left
ventricular ejection fraction of 55%. Subsequent heart
catheterization revealed 99% occlusion of the left anterior
descending artery with extension into the two diagonal
branches, 100% obstruction of the left anterior descend-
ing artery at the trifurcation and 70% lesion affecting the
first posterior lateral branch of the circumflex artery. The
patient was evaluated for possible coronary artery bypass
graft; however, because of his current pulmonary status,
angioplasty was elected with successful stenting of the left
anterior descending artery. On follow up one year out
from stent placement, the patient remained asympto-
matic with exercise tolerance and pulmonary function
returning to baseline.
Conclusion
This is the first report of a cystic fibrosis patient diagnosed
with symptomatic coronary artery disease (CAD) and
acknowledges that adult cystic fibrosis patients have
indeed survived into the years were coronary artery dis-
ease becomes prevalent. Therefore, the likelihood of coro-
nary disease should be included in the diagnostic
consideration of persistent dyspnea associated with chest
discomfort by applying the same standards used in grad-
ing a differential with an anginal presentation in non-CF
patients [5].
The patient presented in this case had a Framingham score
estimate that predicted a 10-year cardiovascular risk at 4%
[6]. However, because of the presence of subtle chest dis-
comfort associated with dyspnea, medical decision mak-
ing includes an active alternative diagnosis of atypical
angina based on two of three positive criteria of exertionalBMC Pulmonary Medicine 2006, 6:9 http://www.biomedcentral.com/1471-2466/6/9
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symptoms with symptom relief upon resting [5]. Persist-
ent dyspnea may be an occasional finding for a cystic
fibrosis patient, and one that typically leads to further
work up of a pulmonary etiology; however, cardiovascular
disease was additionally considered in this patient.
The typical differential diagnosis of persistent dyspnea in
an adult cystic fibrosis patient would include pneumoth-
orax (5% prevalence) [7], atypical mycobacterial pneu-
monia (15% prevalence) [8], allergic bronchopulmonary
aspergillosis (30% prevalence) [9], and cor pulmonale
(3% prevalence in association with severe CF pulmonary
disease) [10]. Without a history for hemoptysis, atypical
mycobacterium and allergic bronchopulmonary aspergil-
losis would be less likely. Physical exam and chest radio-
graph did not support either pneumothorax or congestive
heart failure. Symptoms could also be explained by this
patient's progression of gastroesophageal reflux and/or
Barrett's esophagus.
Atypical angina would be the most prevalent differential
diagnosis, at 60%, for our patient's clinical presentation of
chest pain in the non-CF male patient at this age [5]. The
risk of CAD is not typically considered as an active alter-
native diagnosis for the CF patient; yet with aging, even CF
patients will be at risk for CAD. This risk may even be
greater given higher prevalence of known risk factors such
as diabetes mellitus in the CF versus non-CF patient [11].
Two cases of asymptomatic coronary artery disease have
been reported in association with CF with some advanced
detail. One case came to diagnosis at autopsy, character-
ized as generalized atherosclerosis in a 41-year-old female
CF patient [homozygous G542X] with diabetes mellitus
that died from respiratory failure [12]. Further review of
this case revealed a 200 mg/dl averaged cholesterol level,
progressive hypertension with biopsy proven nephroscle-
rosis by 31-years of age, and a diabetic course complicated
by gastrointestinal pseudoparesis, retinopathy and neu-
ropathy. In this case, coronary artery disease was an inci-
dental finding on autopsy as she was asymptomatic for
myocardial ischemia during her lifetime.
A second case was described in which segmental hypoki-
nesis with grade 2 systolic function was found as an inci-
dental finding on Doppler echocardiography from a
prevalence study looking at pulmonary hypertension that
included an adult cystic fibrosis patient population [10].
This study identified a 40-year-old diabetic male, diag-
nosed with asymptomatic coronary artery disease after
performing a thallium perfusion scan. Further testing by
cardiac catheterization was not reported in this study.
What about other coronary risk factors? Cholesterol and
hypertension were not identified risk factors present in
our patient. The autopsy case report had several risk fac-
tors present, most notably, diabetes and hypertension, but
with only a borderline elevated cholesterol level. What is
the expected lipid level in a CF patient? The largest lipid
study conducted on a CF population reported 134 ± 84
mg/dl triacylglycerol and 138 ± 84 mg/dl total cholesterol
values [14]. Only 4% of patients had cholesterol levels
>200 mg/dl in this study, with a maximum total choles-
terol identified at 240 mg/dl. Serum cholesterol levels can
be highly variable in CF patients. Patients with pancreatic
insufficiency have low to normal cholesterol levels even
with a high fat diet and enzyme supplementation as seen
in this case [15]; however, CF patients with pancreatic suf-
ficiency are likely at the same risk as the general popula-
tion for complications for hyperlipidemia [16]. Another
study of aortic atherosclerosis in CF patients found that
they have less fatty streaking of the aorta than their weight
matched counterparts [17]. Clearly there are other factors
that may lead to atherosclerosis than lipid levels; how-
ever, applying a clinical practice guide published by the
American College of Physicians [5] proved helpful toward
diagnosing CAD in this CF patient presenting with dysp-
nea associated with a chest discomfort.
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